Clinical trial Recruiting at 1 site Observational Ages 18 and up

Subcostal TAP Block and EEG Changes During Laparoscopic Gallbladder Surgery

Official title: Effect of Subcostal Transversus Abdominis Plane Block on Analgesia, EEG Dynamics, and Burst Suppression in Laparoscopic Cholecystectomy

Run by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · NCT07818954 · Data updated 2026-11-12

This observational study tests whether adding a subcostal TAP block to standard IV opioid therapy affects intraoperative brain activity measures and pain needs in adults undergoing laparoscopic cholecystectomy.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 14, 2026
Trial IDNCT07818954 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older undergoing laparoscopic cholecystectomy under general anesthesia, ASA I–III, who consent to participate.

Probably not a fit

Patients with ASA IV–V or those who do not receive the TAP block may not experience any detectable benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational study at Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital. Adult patients undergoing laparoscopic cholecystectomy under general anesthesia are grouped by analgesic technique chosen in routine care: remifentanil alone or remifentanil with an ultrasound-guided subcostal TAP block. The study records intraoperative analgesic use, BIS values, EEG dynamics, and burst suppression, and compares these metrics between groups. Postoperative outcomes such as pain scores, additional analgesic requirements, and recovery metrics are collected. Depth of anesthesia is monitored per standard practice, and data are analyzed to explore associations between TAP block use, analgesic needs, and cerebral electrical activity.

Why it matters

Potential benefit: If successful, the study could clarify whether a subcostal TAP block reduces intraoperative analgesic needs and modulates brain activity patterns during laparoscopic surgery, potentially guiding anesthesia strategies.

How similar studies have gone: Previous work in regional analgesia and intraoperative EEG/BIS monitoring suggests potential benefits, but this specific combination in laparoscopic cholecystectomy is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* American Society of Anesthesiologists (ASA) physical status I-III
* Scheduled to undergo laparoscopic cholecystectomy under general anesthesia
* Written informed consent provided by the participant or, when applicable, the legally authorized representative

Exclusion Criteria:

* Refusal to participate in the study
* American Society of Anesthesiologists (ASA) physical status IV-V
* Known allergy or hypersensitivity to medications used during perioperative anesthetic or analgesic management

Where it's running

  • Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.